AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 13 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 6.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $9,734,000 | -0.1% | 13,000,000 | 0.0% | 0.42% | +18.1% |
Q3 2018 | $9,740,000 | +15.5% | 13,000,000 | 0.0% | 0.35% | +10.3% |
Q2 2018 | $8,436,000 | -15.7% | 13,000,000 | 0.0% | 0.32% | -17.7% |
Q1 2018 | $10,010,000 | -3.1% | 13,000,000 | 0.0% | 0.39% | -2.5% |
Q4 2017 | $10,335,000 | +0.3% | 13,000,000 | 0.0% | 0.40% | +8.4% |
Q3 2017 | $10,303,000 | -2.3% | 13,000,000 | 0.0% | 0.37% | -5.9% |
Q2 2017 | $10,546,000 | +1.4% | 13,000,000 | 0.0% | 0.39% | -3.0% |
Q1 2017 | $10,400,000 | +12.3% | 13,000,000 | 0.0% | 0.40% | +2.0% |
Q4 2016 | $9,263,000 | +8.1% | 13,000,000 | 0.0% | 0.40% | +19.7% |
Q3 2016 | $8,572,000 | +15.7% | 13,000,000 | 0.0% | 0.33% | +9.3% |
Q2 2016 | $7,410,000 | +12.2% | 13,000,000 | 0.0% | 0.30% | +7.5% |
Q1 2016 | $6,606,000 | -23.4% | 13,000,000 | 0.0% | 0.28% | -10.2% |
Q4 2015 | $8,629,000 | -76.6% | 13,000,000 | 0.0% | 0.31% | -76.3% |
Q3 2015 | $36,801,000 | – | 13,000,000 | – | 1.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 1,760,000 | $898,000 | 1.12% |
Telemetry Investments, L.L.C. | 6,000,000 | $3,049,000 | 0.89% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 54,500,000 | $27,693,000 | 0.46% |
ZAZOVE ASSOCIATES LLC | 15,070,000 | $7,761,000 | 0.37% |
ACUTA CAPITAL PARTNERS, LLC | 1,000,000 | $508,000 | 0.28% |
Tekla Capital Management LLC | 13,000,000 | $6,606,000 | 0.28% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,000,000 | $13,910,000,000 | 0.26% |
Castle Creek Arbitrage, LLC | 4,000,000 | $2,081,000 | 0.17% |
WOLVERINE ASSET MANAGEMENT LLC | 10,934,000 | $5,558,000 | 0.16% |
Baker Brothers Advisors | 26,517,000 | $13,526,000 | 0.14% |